Evaluation of Doppler Flow From the Femoral Artery as a Reflection of Cardiac Flow in a Vascular Fluid Test
NCT ID: NCT02878369
Last Updated: 2016-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
140 participants
OBSERVATIONAL
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The reference measurement will increase cardiac output measured by ultrasound.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Color Doppler and Peripheral Venous Catheters
NCT03889678
Central Venous Catheter-Related Thrombosis in Critically Ill Patients
NCT06573112
Validation of Venous Cannulae Flow Ratings
NCT00906906
Venous Pressure Monitoring As a Predictor Of High-Flow Access In Prevalent Hemodialysis Patients
NCT07038993
Determining Occlusion Pressure in Lymphatic Vessels
NCT02359578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Flow measurement in the femoral artery could be an attractive alternative to the cardiac output measurement as:
* It is easy: the femoral vascular ultrasound is booming with resuscitators, including the laying of intravascular catheter or thrombosis diagnosis.
* It is painless: it is based on the application of the ultrasound probe on the root of the thigh for less than 5 minutes.
* It is not subject to limitations echogenicity by interposition of air (except in exceptional circumstances)
* It measures the same physiological parameter (arterial flow) as measuring ultrasound cardiac output (based on measurement of the flow at the outflow tract of the left ventricle).
Pathophysiology study, multicenter (conducted in three French ICUs), open, prospective in order to evaluate the flow doppler from the femoral artery as a reflection of cardiac flow in a vascular fluid test in patient with signs of acute circulatory failure in intensive care unit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Doppler measurement of blood flow in the outflow tract of the left ventricle and the femoral artery,Reading blood pressures displayed on the monitor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Intra-arterial catheter already in place and operational
* Stability blood pressure for 5 min (no change in mean arterial pressure\> 10%, no increase in dose catecholamine)
* Presence of at least one sign of acute circulatory failure from:
* Low blood pressure (mean arterial pressure \<65 mmHg and / or systolic \<90 mmHg)
* tachycardia\> 120 bpm without other obvious cause a circulatory failure
* Oliguria \<1 ml / kg during the last hour suggestive of circulatory failure
* blood Hyperlactataemia\> 2 mmol / l without other obvious cause a systemic circulatory failure (lactate will not be measured for the purposes of the study)
* Smear
* ongoing catecholamine Administration
* Another sign justifying, according to the doctor in charge, vascular filling test (capillary refill time elongated, others ...)
* The doctor in charge has prescribed a fluid loading test, regardless of the needs of the study.
Clear contraindication to the femoral artery Doppler (wound or burn the groin, for example)
* Complete occlusion of the femoral artery or 2 of the aorta requiring or having required a vascular bypass
* Pregnant woman
* Minor
* Major Trust
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nantes
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC13_0486
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.